يعرض 1 - 20 نتائج من 30,456 نتيجة بحث عن '(( has a decrease ) OR ((( a ((mean decrease) OR (_ decrease)) ) OR ( _ largest decrease ))))', وقت الاستعلام: 0.73s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4

    Decadal mean regional hydrology. حسب Nic Gedney (19762301)

    منشور في 2024
    الموضوعات:
  5. 5

    Simulated regional mean wetland seasons. حسب Nic Gedney (19762301)

    منشور في 2024
    الموضوعات:
  6. 6
  7. 7

    Table 3_Multi-omics reveals that NOTCH1 promotes cervical cancer progression and reduces radiosensitivity.xlsx حسب Aihua Guo (13267712)

    منشور في 2025
    "…</p>Conclusions<p>This study clarifies NOTCH1’s role in promoting cervical cancer progression and reducing radiosensitivity, with has-miR-449a as a negative regulator, providing targets for optimizing cervical cancer radiotherapy.…"
  8. 8

    Table 1_Multi-omics reveals that NOTCH1 promotes cervical cancer progression and reduces radiosensitivity.docx حسب Aihua Guo (13267712)

    منشور في 2025
    "…</p>Conclusions<p>This study clarifies NOTCH1’s role in promoting cervical cancer progression and reducing radiosensitivity, with has-miR-449a as a negative regulator, providing targets for optimizing cervical cancer radiotherapy.…"
  9. 9

    Table 2_Multi-omics reveals that NOTCH1 promotes cervical cancer progression and reduces radiosensitivity.docx حسب Aihua Guo (13267712)

    منشور في 2025
    "…</p>Conclusions<p>This study clarifies NOTCH1’s role in promoting cervical cancer progression and reducing radiosensitivity, with has-miR-449a as a negative regulator, providing targets for optimizing cervical cancer radiotherapy.…"
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Decreased production of antiviral factors in patients infected with SARS-CoV-2 due to reduced TLR7 expression حسب Julia Cataldo Lima (22811497)

    منشور في 2025
    "…A decrease in pattern recognition receptors (PRRs) was also observed at both the gene and protein levels. …"
  17. 17
  18. 18
  19. 19

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …"
  20. 20

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …"